Lipid and low-density-lipoprotein apheresis. Effects on plasma inflammatory profile and on cytokine pattern in patients with severe dyslipidemia
Authors:
- Claudia StefanuttiCSClaudia Stefanutti
- Claudia MorozziCMClaudia Morozzi
- Andrea PettaAPAndrea Petta
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Cross-Talk between Apolipoprotein E and CytokinesMediators of Inflammation, 2011
- Familial hypercholesterolemia: Current treatment options and patient selection for low-density lipoprotein apheresisJournal of Clinical Lipidology, 2010
- Lipoprotein(a) as a cardiovascular risk factor: current statusEuropean Heart Journal, 2010
- Elevated circulating levels of macrophage migration inhibitory factor in polycystic ovary syndromeCytokine, 2010
- Cytokine Biomarkers, Endothelial Inflammation, and Atherosclerosis in the Metabolic Syndrome: Emerging ConceptsThe American Journal of the Medical Sciences, 2009
- Lipoprotein(a), Hormone Replacement Therapy, and Risk of Future Cardiovascular EventsJACC, 2008
- Protein adsorption during LDL-apheresis: proteomic analysisNephrology Dialysis Transplantation, 2008
- Inflammation in atherosclerosisNature, 2002
- Modulation of epithelial and endothelial paracellular permeability by leukocytesAdvanced Drug Delivery Reviews, 2000
- Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemiaThe American Journal of Cardiology, 1998